| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |